Mental Health Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
University of California, San Francisco
Diffusion-weighted magnetic resonance imaging needed to monitor disease progression of glioma
December 17th, 2005
Diffusion-weighted magnetic resonance (MR) imaging was recommended to monitor disease progression of glioma. According to recent research from the United States, "Diffusion-weighted MR imaging is an invaluable tool in the diagnosis of acute stroke and other types of brain injury. Abnormalities in and around the resection cavity on diffusion-weighted imaging have been observed following surgery for infiltrating glioma. The purpose of this study was to investigate prospectively the incidence, time course, and ultimate outcome of these abnormalities." "Forty-four consecutive patients with newly diagnosed gliomas were prospectively observed using serial...
Source: Mental Health Law Weekly (2005-12-17)
|
